期刊文献+

CD36mRNA在卵巢颗粒细胞的表达调节及与多囊卵巢综合征的相关性 被引量:1

Expression and regulation of CD36 mRNA in granulosa cells and its relation with clinical characteristics of polycystic ovary syndrome
原文传递
导出
摘要 目的 探讨CD36mRNA在多囊卵巢综合征(PCOS)患者卵巢颗粒细胞的表达,以及不同浓度的睾酮、胰岛素及罗格列酮对正常卵巢颗粒细胞CD36mRNA的表达调节.方法 分别提取5例PCOS患者和5名健康人卵巢颗粒细胞,应用实时荧光定量RT-PCR方法检测CD36mRNA的表达;提取25名健康人卵巢颗粒细胞进行体外培养48 h后,分别用含不同浓度的睾酮、胰岛素及PPARγ的激动剂(罗格列酮)的培养基培养颗粒细胞24 h后,应用RT-PCR方法检测CD36mRNA的表达.结果 (1)PCOS组颗粒细胞CD36 mRNA表达明显高于对照组(P<0.01).(2)颗粒细胞体外培养,当睾酮为1 nmol/L时,CD36 mRNA表达增加,但差异无统计学意义(P>0.05);当睾酮增加到10 nmol/L时,CD36 mRNA表达明显高于对照组(P<0.05).胰岛素为10 nmol/L时,CD36mRNA表达较对照组增加,但差异无统计学意义(P>0.05);当胰岛素进一步增加到100 nmol/L时,CD36mRNA表达较对照组明显增加(P=0.05).罗格列酮为1 nmol/L时,CD36 mRNA表达较对照组明显增加(P<0.05);当罗格列酮增加为10 nmol/L时,CD36 mRNA表达较罗格列酮为l nmol/L时进一步明显增加(P<0.05).结论 (1)卵巢颗粒细胞CD36 mRNA表达可能与PCOS高雄激素血症有关;(2)高浓度的睾酮和胰岛素诱导卵巢颗粒细胞CD36 mRNA表达;(3) CD36 mRNA表达随着罗格列酮浓度的增加而增加,因此颗粒细胞CD36 mRNA表达可能受PPAR的正向调节. Objective To study the expression of CD36 mRNA in granulosa cells (GCs) of patients with polycystic ovary syndrome (PCOS) and the impact of testosterone,insulin and PPARγ agonist rosiglitazone on GCs.Methods The expression of CD36 mRNA inGCs of patients with PCOS and normal controls were assayed byreal-time PCR.The level of CD36 mRNA after treatment with testosterone,insulin,and rosiglitazone in GCs ofnormal controls were also tested by real-time PCR.Results (1) The expression of CD36mRNA in the GCs of PCOS was significantly higher than that of the controls (P 〈 0.05).(2) When testosterone concentration was 1 nmol/L,CD36 mRNA increased in the GCs,but there was no significantdifference compared to the blank control,(P 〉 0.05).When testosterone concentration was l0 nmol/L,the expression of CD36 mRNA in the GCs was higher than that in the blank control with significant difference (P 〈 0.05).When insulin concentration was 10 nmol/L,the expression of CD36 mRNA increased but the difference was not statistically significant (P 〉 0.05).When insulin concentration was 100 nmol/L,the expression of CD36mRNA in the GCswas higher than that in the blank control (P =0.05).When rosiglitazone concentration was I nmol/L,the expression of PPARγ mRNA in GCs were significantly increased compared with the blank control (P 〈 0.05).The expression of CD36 mRNA atrosiglitazone concentrationof 10 nmol/Lwere significantly increased compared to the concentration of 1 nmol/L (P 〈 0.05).Conclusion High testosterone and insulin induced the expression of CD36 mRNA.Rosiglitazone increased CD36 mRNA in a dose-related manner in GCs.Increased CD36 mRNA in the GCs of PCOS may be related to the clinical characteristics of PCOS.
出处 《中华医学杂志》 CAS CSCD 北大核心 2016年第25期2002-2005,共4页 National Medical Journal of China
基金 武警总医院课题资助项目(WZ2012064)
关键词 多囊卵巢综合征 睾酮 胰岛素 Polycystic ovary syndrome Testosterone Insulin
  • 相关文献

参考文献9

  • 1胡振兴,乔杰,李美芝,张小为,陈咏健,李蓉,孙春玲.多囊卵巢综合征相关基因的差异表达研究[J].北京大学学报(医学版),2004,36(6):600-604. 被引量:25
  • 2Febbraio M, Hajjar DP, Silverstein RL. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism [ J]. J Clin Invest, 2001, 108:785-791. DOI : 10.1172/jci200114006.
  • 3Greenaway I, Gentry PA, Feige J J, et al. Thrombospondin and vascular endothelial growth factor are cyclically expressed in an inverse pattern during bovine ovarian follicle development [ J ]. Biol Reprod ,2005, 72(5 ) : 1071-1078.
  • 4Petrik JJ, Gentry PA, Feige J J, et al. Expression and localization of thrombospondin-1 and-2 and their cell-surface receptor, CD36, during rat follicular development and formation of the corpus luteum[J]. Biol Reprod,2002, 67(5) :1522-1531.
  • 5Calvo D, G6mez-Coronado D, Suarez, Y,et al. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL[J]. J Lipid Res, 1998, 39(4) :777-788.
  • 6Scow KM, Tsai YL, Hwang JL, et al. Omental adipose tissue overexpression of fatty acid transporter CD36 and decreased expression of hormone-sensitive lipase in insulin-resistant women with polycystic ovary syndrome. Hum Reprod, 2009, 24 ( 8 ) : 1982-1988. DOI:10. 1093/humrep/dep122.
  • 7Osz K, Ross M, Petrik J. The thrombospondin-I receptor CD36 is an important mediator of ovarian angiogenesis and foHieulogenesis [ J ]. Reprod Biol Endocrino1,2014 , 14 (12) :21.
  • 8Silverstein RL, Febbraio M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior [ J ]. Sci Signal, 2009 , 26;2(72):re3. DOI:10. 1126/scisignal. 272re3.
  • 9Moore K J, Rosen ED, Fitzgerald ML, et al. The role of PPAR- gamma in macrophage differentiation and cholesterol uptake [ J ]. Nat Med,2001,7( 1 ) :41-47.

二级参考文献19

  • 1Kuwasako T, Hirano K, Sakai N, et al. Lipoprotein abnormalities in human genetic CD36 deficiency associated with insulin resistance and abnormal fatty acid metabolism[ J ]. Diabetes Care ,2003,26:1647 -1648
  • 2Kajihara S, Hisatomi A, Ogawa Y, et al. Association of the Pro90Ser CD36 mutation with elevated free fatty acid concentrations but not with insulin resistance syndrome in Japanese [ J]. Clin Chim Acta,2001,314:125 - 130
  • 3Ylitalo K, Nuotio I, Viikari J, et al. C3, hormone-sensitive lipase,and peroxisome proliferator-activated receptor gamma expression in adipose tissue of familial combined hyperlipidemia patients. C3, hormone-sensitive lipase, and peroxisome proliferator-a
  • 4Tabara Y, Kohara K, Yamamoto Y, et al. Polymorphism of the monocyte chemoattractant protein ( MCP-1 ) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness[ J ]. Hypertens Res,2003,26:677 - 683
  • 5Greisen S, Flyvbjerg A, Ledet T, et al. Regulation of insulin-like growth factor binding protein secretion by human granulosa luteal cells in a polycystic ovary-like environment [ J ]. Fertil Steril,2002,78: 162 - 168
  • 6Sayin NC,Gucer F, Balkanli-Kaplan P,et al. Elevated serum TNFalpha levels in normal-weight women with polycystic ovaries or the polycystic ovary syndrome[J]. J Reprod Med, 2003,48:165 -170
  • 7Peral B,San-Millan JL,Castello R,et al. Comment: the methionine196 arginine polymorphism in exon 6 of the TNF receptor 2 gene(TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism [ J ]. J ClinEndocrinol Metab, 2002,87: 3977 -398
  • 8Kondera-Anasz Z, Mielczarek-Palacz A, Switala J. Significantly increased interleukin-1A and interleukin-1 soluble type Ⅱ receptor levels in women with ovarian cancer[ J]. Ginekol Pol,2003,74:761 -766
  • 9Heward JM, Mijovic CH, Kelly MA, et al. HLA-DQ and DRB1 polymorphism and susceptibility to type 1 diabetes in Jamaica[J]. Eur J Immunogenet,2002,29:47 - 52
  • 10Ober C, Weil S, Steck T, et al. Increased risk for polycystic ovary syndrome associated with human leukocyte antigen DOAI * 0501 [ J ].Am J Obstet Gynecol,1992, 167:1803-1806

共引文献24

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部